You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Bulk Pharmaceutical API Sources for MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE

Vendor Vendor Homepage Vendor Sku API Url
Starshine Chemical ⤷  Get Started Free 2023-05-5H06300 ⤷  Get Started Free
RR Scientific ⤷  Get Started Free R5528386 ⤷  Get Started Free
RR Scientific ⤷  Get Started Free R6475073 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE

Last updated: November 24, 2025


Introduction

Marcaine Hydrochloride, a widely utilized local anesthetic, combined with epinephrine, facilitates vasoconstriction, prolonging anesthesia and reducing systemic absorption. However, a preservative-free formulation is crucial for specific patient populations, especially those with allergies or sensitivities. Ensuring a reliable, high-quality source of the active pharmaceutical ingredients (APIs)—bupivacaine hydrochloride (Marcaine) and epinephrine—is paramount for manufacturers and healthcare providers. This article examines the primary sources, quality considerations, and regulatory landscape surrounding these APIs.


Overview of APIs in Marcaine Hydrochloride with Epinephrine

Bupivacaine Hydrochloride is the principal API responsible for local anesthesia, while Epinephrine acts as a vasoconstrictor, extending anesthesia duration and minimizing bleeding. When sourced preservative-free, these APIs must meet stringent standards to ensure safety and efficacy, especially given their injectable administration.


Key API Suppliers for Bupivacaine Hydrochloride

1. TEVA Pharmaceuticals

TEVA is a leading global producer of generic pharmaceuticals, including high-quality bupivacaine hydrochloride APIs. Recognized for adhering to Good Manufacturing Practices (GMP), TEVA supplies APIs globally, often used in various local anesthetic formulations.

2. EuroPharma

An established API manufacturer based in Europe, EuroPharma offers pharmaceutical-grade bupivacaine hydrochloride suitable for injectable products. Their robust quality systems ensure compliance with international standards such as USP and Ph. Eur.

3. Alvogen

Headquartered in the United States, Alvogen supplies bupivacaine APIs that meet industry standards for pharmacopoeial specifications and are suitable for preservative-free formulations.

4. Jiangsu Hengrui Medicine Co., Ltd.

A major Chinese pharmaceutical firm, Hengrui provides a range of APIs, including bupivacaine hydrochloride, with certifications aligning with FDA and EMA standards.

5. American Certified API Manufacturers

Several US-based API producers, such as Monosource or Akorn, manufacture bupivacaine hydrochloride adhering to FDA cGMP guidelines, primarily catering to the North American market.


Epinephrine API Suppliers

1. U.S. Pharmacopeial and European Suppliers

  • Viatris (Mylan): Supplies pharmaceutical-grade epinephrine, meeting USP and Ph. Eur. specifications. Known for high purity and regulatory compliance.
  • Novolog (Novo Nordisk): Their epinephrine API adheres to strict pharmaceutical standards, and supply is tailored for preservative-free preparations.
  • Pharmacore: Based in India, pharmacore provides cost-effective, high-purity epinephrine APIs recognized by regulatory authorities.

2. Chinese API Producers

  • Multiple manufacturers in China, such as Zhejiang Hisun Pharmaceutical Co., Ltd., have established GMP-certified production lines providing epinephrine suitable for injectable formulations.

3. Indian API Manufacturers

  • Companies like Sun Pharmaceutical Industries Ltd. and Aarti Drugs Ltd. are known to offer pharmaceutical-grade epinephrine, adhering to WHO-GMP standards, with some specifically supplying preservative-free APIs.

Quality Considerations for API Sourcing

GMP Compliance: For APIs intended in injectable formulations, particularly preservative-free, adherence to GMP standards is non-negotiable. This ensures the absence of contaminants and consistent API potency.

Pharmacopoeial Standards: SARS-approved sources should meet USP, EP, BP, or JP monographs, specifying limits for residual solvents, heavy metals, and endotoxins.

Purity and Stability: High purity levels (>99%) and stability over shelf life are critical for APIs used in sensitive injectable solutions.

Certification and Documentation: Suppliers should provide comprehensive Certificates of Analysis (CoA), Certificates of Suitability (CoS) where applicable, and regulatory documentation supporting raw material compliance.


Regulatory Landscape and Implications

FDA and EMA Regulations: API sources must be compliant with cGMP, with manufacturers often audited by regulatory agencies to verify adherence.

Global Supply Chain Risks: Political, logistical, and regulatory changes can impact API availability. Diversified sourcing from multiple reputable suppliers mitigates procurement risks.

Preservative-Free Formulation Challenges: APIs intended for preservative-free formulations demand rigorous control over water quality and manufacturing conditions to prevent microbial contamination.


Emerging Trends and Considerations

  • Manufacturing in China and India: These countries continue to expand GMP-certified API production, offering cost-effective options but necessitating thorough due diligence.
  • Quality Assurance: Companies increasingly seek APIs with batch-specific data, stability reports, and validated manufacturing processes.
  • Supply Chain Transparency: Traceability and compliance documentation are vital for regulatory approvals and risk management.

Conclusion

The reliable sourcing of preservative-free bupivacaine hydrochloride and epinephrine APIs remains central to the manufacturing of high-quality Marcaine formulations. Leading suppliers, primarily in the US, Europe, China, and India, offer pharmaceutical-grade APIs complying with international standards. Due diligence encompasses verifying GMP compliance, purity levels, and regulatory certifications, ensuring product safety and efficacy, especially for injections administered without preservatives.


Key Takeaways

  • Diversify suppliers from reputable regions (US, Europe, China, India) to mitigate supply chain risks.
  • Prioritize GMP-certified APIs meeting pharmacopoeial standards for preservative-free injectable formulations.
  • Verify certification documentation such as Certificates of Analysis and Certificates of Suitability.
  • Engage with suppliers capable of providing stable, high-purity, and compliant APIs suitable for sensitive formulations.
  • Monitor regulatory developments to ensure ongoing compliance and adaptability in sourcing strategies.

FAQs

1. Can I source bulk APIs directly for manufacturing preservative-free Marcaine?
Yes, provided the API suppliers comply with GMP standards, can supply pharmacopoeial-compliant products, and offer comprehensive certification. Stringent quality assessment and validation are essential prerequisites.

2. What are the primary factors influencing the choice of API suppliers for preservative-free formulations?
Key factors include GMP certification, API purity, stability, documentation quality, supplier reputation, and regulatory compliance.

3. Are Chinese API manufacturers reliable for high-quality bupivacaine hydrochloride and epinephrine?
Many Chinese manufacturers are GMP-certified and supply pharmaceutical-grade APIs suitable for injectable preparations. It is recommended to conduct thorough audits and review documentation before procurement.

4. How does the absence of preservatives affect API sourcing and quality requirements?
Preservative-free formulations demand APIs of the highest purity to prevent microbial contamination. This necessitates rigorous manufacturing controls, water quality standards, and aseptic processing.

5. What regulatory considerations should be addressed when sourcing APIs internationally?
Compliance with local and international regulations, including GMP, pharmacopoeial standards, and import/export requirements, is vital. Due diligence and validation processes safeguard regulatory approvals and patient safety.


References

  1. U.S. Pharmacopeia, 43rd Revision. 2022. Monograph for Bupivacaine Hydrochloride.
  2. European Pharmacopoeia. 10th Edition. Monograph for Epinephrine.
  3. World Health Organization. WHO Expert Committee on Specifications for Pharmaceutical Preparations, 2018.
  4. FDA Guidance for Industry: Quality Metrics for Drug Manufacturing, 2021.
  5. Global API Manufacturing: Quality and Regulatory Expectations, IMS Health White Paper, 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.